These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18295769)

  • 21. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
    Liang S; Hu Y; Liu C; Qi J; Li G
    Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
    Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
    Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study.
    Lawlor DA; Emberson JR; Ebrahim S; Whincup PH; Wannamethee SG; Walker M; Smith GD; ;
    Circulation; 2003 Mar; 107(9):1260-4. PubMed ID: 12628945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
    Maccario M; Ramunni J; Oleandri SE; Procopio M; Grottoli S; Rossetto R; Savio P; Aimaretti G; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
    Langer RD; Pradhan AD; Lewis CE; Manson JE; Rossouw JE; Hendrix SL; LaCroix AZ; Ridker PM
    Thromb Haemost; 2005 Jun; 93(6):1108-16. PubMed ID: 15968396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
    Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
    In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
    Fischer F; Schulte H; Mohan S; Tataru MC; Köhler E; Assmann G; von Eckardstein A
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):595-602. PubMed ID: 15521962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study.
    Yudkin JS; May M; Elwood P; Yarnell JW; Greenwood R; Davey Smith G;
    Diabetologia; 2002 Mar; 45(3):327-36. PubMed ID: 11914737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
    Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-Like Growth Factor 1 and Risk of Cardiovascular Disease: Results From the UK Biobank Cohort Study.
    Lin J; Yang L; Huang J; Liu Y; Lei X; Chen R; Xu B; Huang C; Dou W; Wei X; Liu D; Zhang P; Huang Y; Ma Z; Zhang H
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e850-e860. PubMed ID: 36810801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study.
    Kurl S; Zaccardi F; Onaemo VN; Jae SY; Kauhanen J; Ronkainen K; Laukkanen JA
    Acta Diabetol; 2015 Feb; 52(1):183-6. PubMed ID: 24974303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
    Wilson PW; Anderson KM; Castelli WP
    Am J Med; 1991 Jan; 90(1):11-6. PubMed ID: 1986576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.